Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study.

Publisher: Sage Publications Country of Publication: England NLM ID: 101234011 Publication Model: Print Cited Medium: Internet ISSN: 1752-8984 (Electronic) Linking ISSN: 14791641 NLM ISO Abbreviation: Diab Vasc Dis Res Subsets: MEDLINE

Publication: 2009- : London : Sage Publications
Original Publication: Edgbaston, Birmingham, UK : Sherborne Gibbs, c2005-

Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/drug therapy ; Glycated Hemoglobin*/metabolism ; Blood Glucose*/metabolism ; Blood Glucose*/drug effects ; Hypoglycemic Agents*/therapeutic use ; Hypoglycemic Agents*/adverse effects ; Blood Glucose Self-Monitoring* ; Glycemic Control*/adverse effects ; Biomarkers*/blood ; Predictive Value of Tests*; Humans ; Prospective Studies ; Treatment Outcome ; Female ; Male ; Middle Aged ; Canada/epidemiology ; Aged ; Time Factors

Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: AA reports grants from Abbott related to the submitted work. AA also reports grants, advisory and speaking fees outside of the submitted work from Abbott, Amgen, Bayer, Novo Nordisk, Janssen, AstraZeneca, Eli Lilly, Boehringer-Ingelheim, Medtroni, Moderna, Senseonics, Dexcom, Insulet, Glaxo-Smith-Kline, Lexicon, Pfizer, and Zucara. ABJ reports research grants, speaking or consulting honoraria from Abbott, Amgen, Novo Nordisk, Acerus, AstraZeneca, Bausch Healthcare, Bayer, Boehringer Ingelheim, Care to Know, CCRN, Connected in Motion, CPD Network, Dexcom, Diabetes Canada, Eli Lilly, Gilead, GSK, HLS Therapeutics, Insulet, Janssen, Master Clinician Alliance, MDBriefcare, Merck, Medtronic, Moderna, Novartis, Novo Nordisk, Partners in Progressive Medical Education, Pfizer, PocketPills, Roche, Sanofi, Takeda, Timed Right and WebMD. MAT reports speaking honoraria from Abbott, NovoNordisk, Eli Lilly, Boehringer-Ingelheim and Janssen. BPG reports speaking honoraria from Abbott, Dexcom and Pfizer as well as consulting honoraria from Abbott, Amgen, Boehringer Ingelheim, Novo Nordisk and Pfizer. JL reports research grants, speaking or consulting honoraria from Abbott, Eli Lilly, Boehringer Ingelheim, Novo Nordisk, Canadian Collaborative Research Network, AstraZeneca and Dexcom. KQ reports speaking or consulting honoraria from Novo Nordisk, Astra Zeneca and Bausch Health. VCW reports speaking honoraria and/or advisory board roles for Abbott, Dexcom, Novo Nordisk and Eli Lilly. CC and JS report no relevant disclosures.

JAMA. 2021 Jun 8;325(22):2262-2272. (PMID: 34077499)
Diabetes Care. 2016 Mar;39(3):e33-5. (PMID: 26721815)
Diabetes Technol Ther. 2023 Oct;25(10):741-751. (PMID: 37471068)
Diabetes Ther. 2017 Feb;8(1):55-73. (PMID: 28000140)
Diabetes Care. 2021 Dec;44(12):2729-2737. (PMID: 34588210)
Diabetes Care. 2022 Jan 1;45(Suppl 1):S97-S112. (PMID: 34964871)
J Diabetes Investig. 2018 Jul;9(4):713-725. (PMID: 29380542)
Diabetes Res Clin Pract. 2022 Jan;183:109172. (PMID: 34883185)
BMJ Open Diabetes Res Care. 2022 Jan;10(1):. (PMID: 35058312)
Psychometrika. 1947 Jun;12(2):153-7. (PMID: 20254758)
Diabetes Res Clin Pract. 2022 Jan;183:109119. (PMID: 34879977)
Diab Vasc Dis Res. 2021 Jul-Aug;18(4):14791641211021374. (PMID: 34275385)
Diabetes Spectr. 2021 May;34(2):184-189. (PMID: 34149259)
Lancet Diabetes Endocrinol. 2022 Dec;10(12):890-900. (PMID: 36356612)

0 (Glycated Hemoglobin)
0 (Blood Glucose)
0 (Hypoglycemic Agents)
0 (hemoglobin A1c protein, human)
0 (Biomarkers)

Date Created: 20240511 Date Completed: 20240511 Latest Revision: 20240610

20240611

PMC11088803

10.1177/14791641241253967

38733368